Skip to Content

W43 (Rosiglitazone Maleate 8 mg (base))

Pill with imprint W43 is Red, Elliptical / Oval and has been identified as Rosiglitazone Maleate 8 mg (base). It is supplied by West-ward Pharmaceutical Corp..

Rosiglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W43

Rosiglitazone Maleate

Imprint:
W43
Strength:
8 mg (base)
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
West-ward Pharmaceutical Corp.
National Drug Code (NDC):
00143-9975

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide